LGM
NERV icon

Logos Global Management’s Minerva Neurosciences NERV Stock Holding History

Logos Global Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3M Buy
3,288,777
+73,777
+2% +$400K 0.79% 39
2026
Q1 		$19.4M Sell
3,215,000
-96,000
-3% -$551K 0.97% 34
2025
Q4 		$13.3M Buy
+3,311,000
New +$12.3M 0.8% 38
2020
Q2 		– Sell
-38,718
Closed -$1.86M – 57
2020
Q1 		$1.86M Buy
38,718
+10,239
+36% +$618K 0.71% 38
2019
Q4 		$1.62M Buy
+28,479
New +$1.26M 0.4% 37

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM

Logos Global Management's NERV Position: Q2 2026 in Review

Logos Global Management increased its Minerva Neurosciences (NERV) stake by 2.3% in Q2 2026, buying an estimated $400K and bringing the position to 3,288,777 shares worth $18.3M. The position accounts for 0.79% of the portfolio, ranked #39.

Logos Global Management first reported a position in NERV in Q4 2019 and has held it in 5 quarters since. The position peaked at $19.4M in Q1 2026. 60 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Logos Global Management held 3,288,777 shares of Minerva Neurosciences worth $18.3M as of Q2 2026.
  • Logos Global Management bought 73,777 Minerva Neurosciences shares in Q2 2026, an estimated $400K.
  • Minerva Neurosciences made up 0.79% of Logos Global Management's portfolio in Q2 2026, its #39 holding.
  • Logos Global Management first reported a position in Minerva Neurosciences in Q4 2019 and has held it in 5 quarters since.
  • Logos Global Management's Minerva Neurosciences position peaked at $19.4M in Q1 2026.
  • 60 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Logos Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.